/
Gall Bladder Cancers in India : Gall Bladder Cancers in India :

Gall Bladder Cancers in India : - PowerPoint Presentation

skylar
skylar . @skylar
Follow
345 views
Uploaded On 2022-06-01

Gall Bladder Cancers in India : - PPT Presentation

A report from Population Based Cancer Registries19822010 Dr Meesha Chaturvedi Indian Council of Medical Research 6112019 1 NCDIRICMR Extreme High High Moderate Low 6112019 ID: 912739

gall icmr 2019 bladder icmr gall bladder 2019 ncdir females cancer cancers c23 age 2010 1984 c24 duct males

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "Gall Bladder Cancers in India :" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript

Slide1

Gall Bladder Cancers in India : A report from Population Based Cancer Registries(1982-2010)

Dr. Meesha

Chaturvedi Indian Council of Medical Research

6/11/2019

1

NCDIR-ICMR

Slide2

Extreme High

High

Moderate

Low

6/11/2019

2

NCDIR-ICMR

GBC incidence rates in the World. Worldwide incidence of GBC in both genders has been mentioned in age standardized rate per 100,000 (www.globocan.iarc.fr). Chile –

9.7; Bolivia – 8.1;

Peru

– 4.0; Ecuador – 4.0; Colombia – 2.8;

Brazil – 1.9; China – 2.8; Japan – 4.7; India – 1.8; Republic of Korea – 6.5; Bangladesh – 4.2; Germany – 2.3; Hungary – 2.9; Poland – 2.9; USA- 1.6; UK – 0.5; France – 1.6; Norway – 1.6.

Slide3

Cancer Atlas in India-Gall Bladder cancers & Ganges River Course6/11/2019

3

NCDIR-ICMR

Slide4

National Cancer Registry Programme Data – INDIA

A Synopsis

6/11/20194

NCDIR-ICMR

Slide5

Comparison of Age Adjusted Incidence Rates (AARs) of All PBCRs (2012-2014)GALLBLADDER (ICD-10: C23-C24)

Males

Females

6/11/2019

5

NCDIR-ICMR

Slide6

Fig: Relative Proportion (%) of GALL BLADDER (ICD-10: C23- C24) cancers to ALL TYPE of Cancers - (Pooled Data 1982-2010)Males

Females

6/11/2019

6

NCDIR-ICMR

Slide7

Proportion (%) and Rank of Gall Bladder Cancersin PBCRs – featured in top 10 leading sites

Registry

Proportion (%)

Rank

Tripura- Females

9.0

4

Cachar- Females

10.6

4

Dibrugarh- Females

9.1

4

Delhi - Females

6.2

5

Kamrup- Females

8.4

5

Manipur State-Females

6.0

5

Kolkata- Males

6.0

5

Sikkim State- Females

5.1

7

Bhopal - Females

3.8

7

Meghalaya- Females

3.8

7

East Khasi hills- Females

3.6

7

Cachar- Males

3.3

9

Dibrugarh-

Males

2.7

10

6/11/2019

7

NCDIR-ICMR

Slide8

Trends in Gall Bladder CancersPBCRs (1982-2010)

6/11/20198

NCDIR-ICMR

Slide9

Gall Bladder (ICD-10 : C23-C24)-Females Trends Over Time in AAR(1982-2011) Five Year Trend

6/11/2019

9NCDIR-ICMR

Slide10

Gall Bladder (ICD-10 : C23-C24)-Females Trends Over Time (2003 -2011) in AAR(Range of Years) - Joinpoint regression-NEWER PBCRs

6/11/2019

10NCDIR-ICMR

Slide11

Changes in Broad Age Groups – Females (Bangalore) 

6/11/2019

11

NCDIR-ICMR

↑ in AARs for 65 and above age group of Bangalore PBCR.

Slide12

 

6/11/2019

12NCDIR-ICMR

Changes in Broad Age Groups – Females (Bhopal)

 

↑ in AARs for

25-34

35-44 and 45-54 age group of Bhopal PBCR.

Slide13

 6/11/2019

13

NCDIR-ICMR

Changes in Broad Age Groups – Females (Chennai)

 

↑ in AARs for

25-34

35-44 and 65 and above age group

Chennai

PBCR.

Slide14

Table: Projected Cases at India level (2015 and 2020)*Gall Bladder and Extra Hepatic Ducts (ICD-10: C23-24)

2020

Males

36046

Females

55141

Both Sexes

91187

All Cancers

1734886

% to All cancers

5.2

*Three-year Report of the PBCRs: 2012-2014, Bengaluru, 20166/11/201914NCDIR-ICMREstablishment of Population Based Cancer Registries in the Gangetic Belt in Allahabad (the land of Kumbh Mela),Aligarh and Patna India.

Slide15

Hospital Based Cancer Registry on Gall Bladder Cancers(1984-2010)

6/11/201915

NCDIR-ICMR

Slide16

Proportion (%) of Gall Bladder Cancers

(ICD10: C23 - 24)

according to Method of Diagnosis (1984 – 2010)

Males

Females

*Data from HBCR Reports 1984 to 2010

Microscopic

Imaging techniques

6/11/2019

16

NCDIR-ICMR

Slide17

Proportion (%) of Microscopically Diagnosed Gall Bladder Patients (ICD10: C23 - 24)

(1984 – 2010)

MalesFemales

*Data from HBCR Reports 1984 to 2010

6/11/2019

17

NCDIR-ICMR

Slide18

Clincial

Extent of Disease

Males

Females

#

%

#

%

Localised (L)

526

16.7

481

12.7

Regional (R)

769

24.4

772

20.5

L + R

1295

41.2

1253

33.2

Distant

1489

47.3

2059

54.6

Others

62

2.0

92

2.4

Unknown

300

9.5

370

9.8

Total

3146

100.0

3774

100.0

Number (#) and

Proporation

(%) of Gall Bladder Cancer patients (ICD10: C23 - 24) according to Clinical Extent of Disease

(Excludes Patients Previously Treated)*Data from HBCR Reports 1984 to 20106/11/201918NCDIR-ICMR

Slide19

Number (#) and Proportion (%) of Gall Bladder Cancer patients (ICD10: C23 - 24) according to Type of Treatment Given at Reporting Institution (1984 – 2010)

Type of Treatment

Males

Females

#

%

#

%

Surgery (S)

495

55.3

392

43.4

Radiotherapy (R)

455.0

56

6.2

Chemotherapy (C)

223

24.9

273

30.2

S + R

27

3.0

32

3.5

S + C

69

7.7

114

12.6

R + C

12

1.3

19

2.1

S + R + C

11

1.2

5

0.6

Others

13

1.5

13

1.4Total895100.0904100.0*Data from HBCR Reports 1984 to 20106/11/201919NCDIR-ICMR

Slide20

Morphologies for Cancer Gall Bladder (23-C24)

Rank

PHM

%

1

ADENOCARCINOMA (8140 )

60.8

2

MALIGNANCY (8000 )

24.4

3

CARCINOMA (8010 )

6.1

4

CHOLANGIOCARCINOMA(C22.1,C24.0) (8160 )

1.7

5

PAPILLARY ADENOCARCINOMA (8260 )

1.1

6

SQUAMOUS CELL CARCINOMA (8070 )

0.9

7

ADENOSQUAMOUS CARCINOMA (8560 )

0.5

8

MUCIN-PRODUCING ADENOCARCINOMA (8481 )

0.5

9

NEUROENDOCRINE CARCINOMA (8246 )

0.4

10

MUCINOUS ADENOCARCINOMA (8480 )

0.4

11

SIGNET RING CELL CARCINOMA (8490 )

0.3

12

TUMOR CELLS, MALIGNANT (8001 )

0.2

13

CARCINOMA, UNDIFFERENTIATED (8020 )

0.1

14

SMALL CELL CARCINOMA (8041 )

0.1

 

Total

Cases

100.0

Slide21

Risk Factors6/11/2019

21

NCDIR-ICMR

Slide22

Risk Factors for Gall Bladder Disease/Cancers

Geographic Pathology

Genetic Predisposition

Infections i.e. Salmonella, Helicobactor

6/11/2019

22

NCDIR-ICMR

Slide23

M

issed Opportunities- CLINICAL - Gall Bladder Cancers

6/11/201923

NCDIR-ICMR

Slide24

M

issed Opportunities- DIAGNOSTIC - Gall Bladder Cancers

6/11/201924

NCDIR-ICMR

Slide25

M

issed Opportunities- STAGING & SURVIVAL- Gall Bladder Cancers

6/11/2019

25NCDIR-ICMR

Slide26

To identify environmental high risk regions for

gall bladder cancer and correlation with ground water arsenic in the state of Assam, India.

Incidental Gall Bladder Cancer and Other Pre malignant Gall Bladder Condition in India towards early Detection of Gall Bladder Cancer

Patterns of Care and Survival Studies –

Gall Bladder Cancers.

6/11/2019

26

NCDIR-ICMR

Slide27

Roadmap Forward (1/2)Synchronization between Registry and clinical practice.Consensus on aspects of staging and treatment for Gall Bladder cancers.Specific studies on preventable risk factors, early diagnostic and prognostic markers .

6/11/2019

27NCDIR-ICMR

Slide28

Roadmap Forward (2/2)Disease Free survival for cases with Ca Gall BladderSpecial registries on Gall Bladder Cancer : customized to scientific requirement (Geographic pathology needs to be revisited).Long term benefit in planning screening programmes in future.

6/11/2019

28NCDIR-ICMR

Slide29

AcknowledgementsPopulation based Cancer RegistriesHospital Based Cancer RegistriesNCDIR-NCRPIndian Council of Medical Research (ICMR)

6/11/2019

29NCDIR-ICMR

Slide30

International Classification of Diseases for Oncology (ICD-O)

C23 Gallbladder

C23.9 Gallbladder

C24 Other and Unspecified Parts of Biliary Tract

C24.0 Extrahepatic Bile Duct

Bile Duct, NOS

Biliary Duct, NOS

Choledochal Duct

Common Bile Duct

Common Duct

Cystic Bile Duct

Cystic Duct Hepatic Bile Duct Hepatic Duct Sphincter of Oddi

C24.1 Ampulla of Vater PeriampullaryC24.8 Overlapping lesion of biliary tract(Note: Neoplasms involving both intrahepatic and extrahepatic bile ducts)C24.9 Biliary Tract, NOS6/11/201930NCDIR-ICMR

Slide31

Exposure to certain chemicals and heavy metals, age, female gender, family history, obesity, cholelithiasis, chronic cholecystitis, porcelain gallbladder, polyps, and chronic infection by Salmonella species

Environmental Factors

Gallbladder Cancer Pathogenesis

Genetic Factors

Genes of Drug Metabolism pathway, Hormonal pathway, Inflammatory pathway, DNA Repair pathway, Hedgehog pathway, Apoptotic pathway, Wnt signaling pathway, miRNA and some other

Schematic representation of factors contributing to GBC pathogenesis

6/11/2019

31

NCDIR-ICMR

Slide32

6/11/2019

32

NCDIR-ICMR

Slide33

Number (#) and Proportion (%) of Gall Bladder Cancers(ICD10: C23 - 24) by Five Year Age Groups (1984 – 2010)

Age Group

Males

Females

#

%

#

%

00-04

-

-

-

05-09

-- 

-

-

10-14

-

1

0.0

15-19

3

0.1

5

0.1

20-24

21

0.5

25

0.5

25-29

57

1.4

68

1.3

30-34

133

3.3

186

3.5

35-39

281

7.0

412

7.840-4443610.867312.745-4954413.587716.650-5462915.691117.255-5964115.972113.660-6450812.6689

13.0

65-69

422

10.5

404

7.6

70-74

221

5.5

204

3.9

75+

122

3.0

115

2.2

Unknown

3

0.1

1

0.0

All Ages

4021

100.0

5292

100.0

*Data from HBCR Reports 1984 to 2010

6/11/2019

33

NCDIR-ICMR

Slide34

To identify environmental high risk regions for

gall bladder cancer and correlation with ground water arsenic in the state of Assam, India.

Life Style Behavior, Dietary Habits, Reproductive factors and risk of

Gall Bladder Cancer in Upper Assam

A multidisciplinary case control study on

Gall bladder cancer -

Identification of modifiable risk factors and risk reduction.

6/11/2019

34

NCDIR-ICMR